BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 35054972)

  • 1. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.
    Fahed G; Aoun L; Bou Zerdan M; Allam S; Bou Zerdan M; Bouferraa Y; Assi HI
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.
    Rochlani Y; Pothineni NV; Kovelamudi S; Mehta JL
    Ther Adv Cardiovasc Dis; 2017 Aug; 11(8):215-225. PubMed ID: 28639538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress.
    Spahis S; Borys JM; Levy E
    Antioxid Redox Signal; 2017 Mar; 26(9):445-461. PubMed ID: 27302002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome.
    Wittwer J; Bradley D
    Front Immunol; 2021; 12():612496. PubMed ID: 33717095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in metabolic syndrome.
    Prasun P
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165838. PubMed ID: 32428560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases.
    Nguyen TTB; Jin YY; Chung HJ; Hong ST
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29064399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links.
    Zafar U; Khaliq S; Ahmad HU; Manzoor S; Lone KP
    Hormones (Athens); 2018 Sep; 17(3):299-313. PubMed ID: 30171523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in metabolic syndrome.
    Cho YH; Lee Y; Choi JI; Lee SR; Lee SY
    Adv Clin Chem; 2022; 111():101-156. PubMed ID: 36427908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent research progress on metabolic syndrome and risk of Parkinson's disease.
    Li LY; Liu SF; Zhuang JL; Li MM; Huang ZP; Chen YH; Chen XR; Chen CN; Lin S; Ye LC
    Rev Neurosci; 2023 Oct; 34(7):719-735. PubMed ID: 36450297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Biomarkers and Components of Metabolic Syndrome in Adolescents: a Systematic Review.
    de F Rocha AR; de S Morais N; Priore SE; do C C Franceschini S
    Inflammation; 2022 Feb; 45(1):14-30. PubMed ID: 34546513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches.
    Peyter AC; Armengaud JB; Guillot E; Yzydorczyk C
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New markers in metabolic syndrome.
    Son DH; Ha HS; Park HM; Kim HY; Lee YJ
    Adv Clin Chem; 2022; 110():37-71. PubMed ID: 36210076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Link between Metabolic Syndrome and Insulin Resistance.
    Gluvic Z; Zaric B; Resanovic I; Obradovic M; Mitrovic A; Radak D; Isenovic ER
    Curr Vasc Pharmacol; 2017; 15(1):30-39. PubMed ID: 27748199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting inflammation in metabolic syndrome.
    Welty FK; Alfaddagh A; Elajami TK
    Transl Res; 2016 Jan; 167(1):257-80. PubMed ID: 26207884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of Metabolic Syndrome and Dietary Intervention.
    Xu H; Li X; Adams H; Kubena K; Guo S
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30602666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Lipids in the Pathogenesis of Metabolic Syndrome in Adolescents.
    Taghizadeh S; Alizadeh M
    Exp Clin Endocrinol Diabetes; 2018 Jan; 126(1):14-22. PubMed ID: 29117624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implication of hepatokines in metabolic syndrome.
    Esfahani M; Baranchi M; Goodarzi MT
    Diabetes Metab Syndr; 2019; 13(4):2477-2480. PubMed ID: 31405664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Effects of n-3 LCPUFAs: A Role in Pediatric Metabolic Syndrome.
    Amatruda M; Ippolito G; Vizzuso S; Vizzari G; Banderali G; Verduci E
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral obesity and metabolic syndrome: two faces of the same medal?
    Scaglione R; Di Chiara T; Cariello T; Licata G
    Intern Emerg Med; 2010 Apr; 5(2):111-9. PubMed ID: 19998063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
    Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
    Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.